These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24119365)

  • 1. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
    Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
    Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
    Sillars B; Davis WA; Hirsch IB; Davis TM
    Diabetes Obes Metab; 2010 Sep; 12(9):757-65. PubMed ID: 20649627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed type 2 diabetes and risk of dementia: a population-based 7-year follow-up study in Taiwan.
    Cheng PY; Sy HN; Wu SL; Wang WF; Chen YY
    J Diabetes Complications; 2012; 26(5):382-7. PubMed ID: 22785052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
    Gulliford M; Latinovic R
    Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
    Chan CW; Yu CL; Lin JC; Hsieh YC; Lin CC; Hung CY; Li CH; Liao YC; Lo CP; Huang JL; Lin CH; Wu TJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):20. PubMed ID: 29368615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy.
    Parlani G; De Rango P; Cieri E; Verzini F; Giordano G; Simonte G; Isernia G; Cao P
    J Vasc Surg; 2012 Jan; 55(1):79-89; discussion 88-9. PubMed ID: 22056251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke.
    Floyd JS; Wiggins KL; Sitlani CM; Flory JH; Dublin S; Smith NL; Heckbert SR; Psaty BM
    Diabetes Obes Metab; 2015 Dec; 17(12):1194-7. PubMed ID: 26179389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study.
    Lin HC; Kachingwe BH; Lin HL; Cheng HW; Uang YS; Wang LH
    Pharmacotherapy; 2014 Jan; 34(1):36-45. PubMed ID: 23864581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan.
    Lai YJ; Hu HY; Lee YL; Ku PW; Yen YF; Chu D
    BMC Cardiovasc Disord; 2017 May; 17(1):130. PubMed ID: 28532430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK.
    Kostev K; Rathmann W
    Prim Care Diabetes; 2013 Jul; 7(2):167-71. PubMed ID: 23478140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
    Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
    Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
    Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.